Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,497,812
-$2,401,550 QoQ
Shares Held
1,578,125
-0.1% QoQ
Ownership
1.77%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#20
of 242 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. SNDX ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in SNDX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,497,812 | 1,578,125 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $36,899,362 | 1,579,596 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,097,125 | 1,146,936 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,964,258 | 712,659 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,216,033 | 556,971 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,582,410 | 780,009 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,855,060 | 669,823 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,065,009 | 886,494 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,112,341 | 930,947 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,101,537 | 718,552 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $11,581,620 | 535,938 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,266,323 | 431,565 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $1,460,849 | 69,169 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $1,817,679 | 94,474 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,894,128 | 224,058 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,064,340 | 322,720 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,101,717 | 109,980 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,928,860 | 112,339 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,398,017 | 241,414 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $13,229,931 | 594,871 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,345,929 | 226,689 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,258,299 | 354,811 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $710,910 | 64,805 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||